Chinese gene testing firm Genetron snags $71m from Vivo Capital, others

Chinese gene testing firm Genetron snags $71m from Vivo Capital, others

Photo by Louis Reed on Unsplash

21 November, 2019

Alexandria Venture Investments CICC Healthcare Investment Fund gene detection Genetron Vivo Capital

Printed by Unregistered user on Sat, 27 Dec 2025 10:20:52 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

China Digest: Kingsoft Cloud, CECport, Genetron Health, Touna and Xiaoman raise fresh funds

Venture Capital

Matrix-backed Chinese biotech startup Genecast closes $43m Series D1 round

Read more from Greater China

China eases IPO rules for firms developing reusable rockets

UBTech buys Shenzhen-listed Fenglong Electric with eye on mainland listing